Circassia Pharmaceuticals Plc (CIR) - Financial and Strategic SWOT Analysis Review

  • ID: 4284731
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Circassia Pharmaceuticals
1 of 4

Circassia Pharmaceuticals plc (Circassia) develops treatments for allergy and respiratory diseases such as asthma. The company’s product line includes NIOX, which is used to improve asthma management by assisting in diagnosis. In addition, the company's pipeline includes a number of inhaled medicines for chronic obstructive pulmonary disease (COPD) treatment, including single and combination dose products. Circassia’s products find application in the treatment of allergies and autoimmune conditions caused by cat, house dust mite, grass and ragweed. The company caters to allergy and asthma specialists in the US, the UK, Germany and other countries through its network of partners. Circassia is headquartered in Oxford, England, the UK.

Circassia Pharmaceuticals Plc Key Recent Developments

Feb 13, 2018: Circassia Announces Changes to its Board of Directors
Nov 29, 2017: Circassia Welcomes New NICE Guidelines Recommending Use of FeNO Testing in Asthma Diagnosis
Sep 27, 2017: Circassia Pharmaceuticals: Interim Results for the Six Months Ended 30 June 2017
Apr 25, 2017: Circassia Pharmaceuticals: Preliminary Results for the Year Ended 31 December 2016
Apr 25, 2017: Circassia Announces Non-Executive Director Retirements

This comprehensive SWOT profile of Circassia Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Circassia Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Circassia Pharmaceuticals Plc - Key Information
  • Circassia Pharmaceuticals Plc - Overview
  • Circassia Pharmaceuticals Plc - Key Employees
  • Circassia Pharmaceuticals Plc - Key Employee Biographies
  • Circassia Pharmaceuticals Plc - Key Operational Heads
  • Circassia Pharmaceuticals Plc - Major Products and Services
  • Circassia Pharmaceuticals Plc - History
  • Circassia Pharmaceuticals Plc - Company Statement
  • Circassia Pharmaceuticals Plc - Locations And Subsidiaries
  • Circassia Pharmaceuticals Plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Circassia Pharmaceuticals Plc - Business Description
  • Circassia Pharmaceuticals Plc - Corporate Strategy
  • Circassia Pharmaceuticals Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Circassia Pharmaceuticals Plc - Strengths
  • Circassia Pharmaceuticals Plc - Weaknesses
  • Circassia Pharmaceuticals Plc - Opportunities
  • Circassia Pharmaceuticals Plc - Threats
  • Circassia Pharmaceuticals Plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Circassia Pharmaceuticals Plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Circassia Pharmaceuticals Plc, Key Information
  • Circassia Pharmaceuticals Plc, Key Ratios
  • Circassia Pharmaceuticals Plc, Share Data
  • Circassia Pharmaceuticals Plc, Major Products and Services
  • Circassia Pharmaceuticals Plc, History
  • Circassia Pharmaceuticals Plc, Key Employees
  • Circassia Pharmaceuticals Plc, Key Employee Biographies
  • Circassia Pharmaceuticals Plc, Key Operational Heads
  • Circassia Pharmaceuticals Plc, Other Locations
  • Circassia Pharmaceuticals Plc, Subsidiaries
  • Circassia Pharmaceuticals Plc, Key Manufacturing facilities
  • Circassia Pharmaceuticals Plc, Key Competitors
  • Circassia Pharmaceuticals Plc, SWOT Analysis
  • Circassia Pharmaceuticals Plc, Ratios based on current share price
  • Circassia Pharmaceuticals Plc, Annual Ratios
  • Circassia Pharmaceuticals Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Circassia Pharmaceuticals Plc, Performance Chart
  • Circassia Pharmaceuticals Plc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown